Pre-clinical models for evaluating glioma targeted immunotherapies
Gliomas have an extremely poor prognosis in both adult and pediatric patient populations as these tumors are known to grow aggressively and respond poorly to standard of care treatment. Currently, treatment for gliomas involves surgical resection followed by chemoradiation therapy. However, some gli...
Main Authors: | Stephen C. Frederico, Xiaoran Zhang, Baoli Hu, Gary Kohanbash |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1092399/full |
Similar Items
-
Myeloid cells as potential targets for immunotherapy in pediatric gliomas
by: Stephen C. Frederico, et al.
Published: (2024-03-01) -
Neoadjuvant immune checkpoint inhibition in the management of glioblastoma: Exploring a new frontier
by: Stephen C. Frederico, et al.
Published: (2023-02-01) -
ImmunoPET imaging of TIGIT in the glioma microenvironment
by: Sarah R. Vincze, et al.
Published: (2024-03-01) -
Glioma Immunotherapy: Advances and Challenges for Spinal Cord Gliomas
by: Clare Grady, et al.
Published: (2022-03-01) -
Stereotactic Injection of DTI-015 into Recurrent Malignant Gliomas: Phase I/II Trial
by: Samuel J. Hassenbusch, et al.
Published: (2003-01-01)